Login
← Go Back
Syngene International
SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com
Stock Price vs Company Growth
1d
0.4%
1w
3.4%
1m
3.8%
3m
14.4%
6m
5.1%
1y
40.1%
5y
8.6%
10y
5.0%
all
8.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 388 0.4%
376
462
Company Overview
Sales
3,600 Cr
Growth: 2.5%
Profit after Tax
221 Cr
Growth: -30.2%
Mid Cap
15,664 Cr
P/E: 70.5x
Industry P/E: 34.2x
Fundamentals
Sales (Cr) ₹ 3,600
Growth 2.5%
EBITDA 22.3%
P/S 4.3x
Dividend 0.2%
P/E 70.5x
Book Value ₹ 120
PEG Ratio 28.3x
ROE 4.5%
P/B 3.3x
Shareholding Pattern
Institutions
Government Pension Fund Global
1.14 %
Uti-Mid Cap Fund
1.03 %
Qualified Institutional Buyer
0.15 %
Promoters
Biocon Limited
70.1 %
Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)
0.32 %
Yamini R Mazumdar
0.01 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is a contract research, development, and manufacturing services company that offers a broad range of scientific services from the earliest stages of discovery to commercial supplies. This positions the Company as an end-to-end service provider within its sector.
Belongs to (30 Indices) view more
Investors (435)
mahesh.g...
ajit.man...
ramakris...
Followers (15)
yogesh
nitin2
keerthi